drugset / Trial / NCT00380874
Prevention And Treatment Of Chemotherapy-Induced Peripheral Neuropathy In Subjects With Advanced Colorectal Cancer
RandomizedParallel-groupDouble-blindTreatment
Summary
Prevention and treatment of the severity of symptoms of chemotherapy-induced peripheral neuropathy.
Timeline
- Start
- 2007-01
- Primary completion
- 2008-03
- Completion
- 2008-03
Outcome
Missed primary endpoint
Stopped: “See detailed description for termination reason”
registry analysis (unspecified test); Pregabalin vs Placebo; p = 0.7489; Median Difference (Final Values) -0.16; ANCOVA NCT00380874 ↗
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Pregabalin | Small molecule | 150 mg | — |
| Subject | Pregabalin | Small molecule | 600 mg | — |